Azemiglitazone
Azemiglitazone (MSDC-0602) is a novel insulin-sensitizing agent investigated for type 2 diabetes treatment. Research in vitro and in vivo demonstrates its potential to improve glycemic control by targeting mitochondrial pyruvate transport.
Product Specifications
CAS Number
1133819-87-0
Product Name Alternative
Azemiglitazone, MSDC 0602, MSDC0602, MSDC-0602, mTOR, inhibit, MitochondrialMetabolism, Mitochondrial Metabolism, Inhibitor
Field of Research
Metabolism Research, Molecular Biology, Signal Transduction
Purity
97.02% (May vary between batches)
Solubility
DMSO:125 mg/mL (336.56 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (10.77 mM) ; H2O:< 0.1 mg/mL (insoluble)
Smiles
COc1cccc (c1) C (=O) COc1ccc (CC2SC (=O) NC2=O) cc1
Molecular Formula
C19H17NO5S
Molecular Weight
371.41
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-33221M-BF594 100 µL
GRP78/Bip Monoclonal Antibody, AbBy Fluor™ 594 Conjugated
Sign In for Pricing
View Details 
39058126 3x 1.0µg DNA
RGD1309139 CRISPRa sgRNA lentivector (set of three targets)(Rat)
Sign In for Pricing
View Details